This partly agrees with results that APOE ε4-negative AD patients have less temporal lobe atrophy [12] and hypometabolism [46] but more frontoparietal atrophy [11, 13] compared with APOE ε4-positive patients. This evidence concerns the gene APOE and Alzheimer disease.